proteomics
Proteomics
The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeating the disease.
Nomic Bio, Parker Institute for Cancer Immunotherapy Team up to Study Treatment Response
The collaboration will focus on identifying protein biomarkers associated with immunotherapy response across cancer types.
Ipsen, Foreseen Biotechnology Ink $1.03B Licensing Deal for Novel Antibody-Drug Conjugate
Ipsen will acquire exclusive rights to develop and commercialize FS001, an antibody-drug conjugate targeting a novel tumor antigen that Foreseen identified.
Sengenics Partners With Duke Health to Study Autoantibody Biomarkers for Colon Cancer
The collaborators will explore the role of autoantibody biomarkers in metastatic colorectal cancer and measure humoral immune responses to Tecentriq and Avastin.
Mayo Clinic Launches Four-Pillar Strategy to Bring Omics Into Patient Care
With the omics strategy, the health system aims to integrate precision medicine, genomic testing, and data into patient care.
Aug 23, 2023
Oct 5, 2022
May 10, 2022
OncoHost Raises $35M in Series C Financing
Jan 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
May 30, 2019